TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,604,894
|
1,393,258
|
1,300,178 |
Financial expenses |
80
|
7,983
|
4,505 |
Earnings before taxes |
121,196
|
56,386
|
55,665 |
EBITDA |
256,727
|
208,542
|
233,157 |
Total assets |
1,227,871
|
941,593
|
1,298,585 |
Current assets |
446,427
|
297,346
|
548,974 |
Current liabilities |
254,857
|
240,031
|
196,439 |
Equity capital |
781,002
|
681,987
|
692,954 |
- share capital |
16,792
|
16,706
|
18,178 |
Employees (average) |
1,065
|
984
|
882 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.6%
|
72.4%
|
53.4% |
Turnover per employee |
1,507
|
1,416
|
1,474 |
Profit as a percentage of turnover |
7.6%
|
4.0%
|
4.3% |
Return on assets (ROA) |
9.9%
|
6.8%
|
4.6% |
Current ratio |
175.2%
|
123.9%
|
279.5% |
Return on equity (ROE) |
15.5%
|
8.3%
|
8.0% |
Change turnover |
204,460
|
198,396
|
-71,366 |
Change turnover % |
15%
|
17%
|
-5% |
Chg. No. of employees |
81
|
102
|
-6 |
Chg. No. of employees % |
8%
|
12%
|
-1% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.